These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23098000)

  • 1. Prothrombin complex concentrate (PCC) and its effect on reversing newer oral anticoagulants.
    Kappes J
    S D Med; 2012 Oct; 65(10):396-7. PubMed ID: 23098000
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
    Eerenberg ES; Kamphuisen PW; Sijpkens MK; Meijers JC; Buller HR; Levi M
    Circulation; 2011 Oct; 124(14):1573-9. PubMed ID: 21900088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model.
    Godier A; Durand M; Emmerich J; Dizier B; Lecompte T; Samama CM
    Thromb Haemost; 2011 Jan; 105(1):161-8. PubMed ID: 20941458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
    Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
    Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose.
    Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K
    Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin complex concentrates: an update.
    Franchini M; Lippi G
    Blood Transfus; 2010 Jul; 8(3):149-54. PubMed ID: 20671873
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.
    Ostermann H; Haertel S; Knaub S; Kalina U; Jung K; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):790-7. PubMed ID: 17938803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
    MacGregor IR; Ferguson JM; McLaughlin LF; Burnouf T; Prowse CV
    Thromb Haemost; 1991 Nov; 66(5):609-13. PubMed ID: 1803625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study.
    Demeyere R; Gillardin S; Arnout J; Strengers PF
    Vox Sang; 2010 Oct; 99(3):251-60. PubMed ID: 20840339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.
    van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF
    Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of hirudin on thrombosis induced by prothrombin complex concentrates.
    Klöcking HP; Schulze-Riewald H; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):106-9. PubMed ID: 2459002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of hemolysates on the coagulation of rabbit plasma].
    Lambert PH
    C R Seances Soc Biol Fil; 1966; 160(1):202-4. PubMed ID: 4222920
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of prothrombin complex concentrate in healthy subjects.
    Barco S; Picchi C; Trinchero A; Middeldorp S; Coppens M
    Br J Haematol; 2017 Feb; 176(4):664-666. PubMed ID: 27027385
    [No Abstract]   [Full Text] [Related]  

  • 19. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation.
    Liu L; Duan JA; Tang Y; Guo J; Yang N; Ma H; Shi X
    J Ethnopharmacol; 2012 Jan; 139(2):381-7. PubMed ID: 22123200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.